These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36672639)

  • 1. Direct Oral Anticoagulants for Stroke Prevention in Special Populations: Beyond the Clinical Trials.
    Carbone A; Bottino R; D'Andrea A; Russo V
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review.
    Owens RE; Kabra R; Oliphant CS
    Clin Cardiol; 2017 Jun; 40(6):407-412. PubMed ID: 28004413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?
    Anderson SL; Marrs JC
    Curr Cardiol Rep; 2019 Aug; 21(10):118. PubMed ID: 31473836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation.
    Oertel LB; Fogerty AE
    J Am Assoc Nurse Pract; 2017 Sep; 29(9):551-561. PubMed ID: 28805310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review and Meta-Analysis: Can We Compare Direct Oral Anticoagulants to Warfarin in Patients With Atrial Fibrillation and Bio-Prosthetic Valves?
    Adhikari G; Baral N; Rauniyar R; Karki S; Abdelazeem B; Savarapu P; Isa S; Khan HMW; Khan MR; Changezi HU
    Cureus; 2021 Apr; 13(4):e14651. PubMed ID: 34046282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Chan YH; Lee HF; Chao TF; Wu CT; Chang SH; Yeh YH; See LC; Kuo CT; Chu PH; Wang CL; Lip GYH
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):701-710. PubMed ID: 31745687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
    Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
    Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Bioprosthetic Valves-A Systematic Review and Meta-analysis.
    Ruzieh M; Wolbrette DL; Naccarelli GV
    J Innov Card Rhythm Manag; 2021 Dec; 12(12):4797-4805. PubMed ID: 34970469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
    Blomström Lundqvist C; Själander S; Garcia Rodriguez LA; Åkerborg Ö; Jin G; Caleyachetty A; Huelsebeck M; Bowrin K; Schaefer B; Mahdessian H; Hofmeister L; Levin LÅ
    J Med Econ; 2022; 25(1):1085-1091. PubMed ID: 35997241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves.
    Duan L; Doctor JN; Adams JL; Romley JA; Nguyen LA; An J; Lee MS
    Am J Cardiol; 2021 May; 146():22-28. PubMed ID: 33529622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations.
    Stacy ZA; Richter SK
    Ther Adv Cardiovasc Dis; 2018 Sep; 12(9):247-262. PubMed ID: 30081727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of direct oral anticoagulant use on mortality in very old patients with non-valvular atrial fibrillation.
    Takahashi M; Okawa K; Morimoto T; Tsushima R; Sudo Y; Sakamoto A; Sogo M; Ozaki M; Doi M; Morita H; Okumura K; Ito H
    Age Ageing; 2022 Jul; 51(7):. PubMed ID: 35776672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016.
    Ardeshirrouhanifard S; An H; Goyal RK; Raji MA; Segal JB; Alexander GC; Mehta HB
    Pharmacotherapy; 2022 May; 42(5):375-386. PubMed ID: 35364622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulation for stroke prevention amongst atrial fibrillation patients with valvular heart disease: an update.
    Ha AC; Verma A; Verma S
    Curr Opin Cardiol; 2017 Mar; 32(2):174-180. PubMed ID: 27861189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Oral Anticoagulant Use in Special Populations: Elderly, Obesity, and Renal Failure.
    White EM; Coons JC
    Curr Cardiol Rep; 2021 Mar; 23(4):27. PubMed ID: 33655373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and an Aortic Bioprosthetic Valve.
    Miyake M; Takegami M; Obayashi Y; Amano M; Kitai T; Fujita T; Koyama T; Tanaka H; Ando K; Komiya T; Izumo M; Kawai H; Eishi K; Yoshida K; Kimura T; Nawada R; Sakamoto T; Shibata Y; Fukui T; Minatoya K; Tsujita K; Sakata Y; Kimura T; Sugio K; Takita A; Iwakura A; Tamura T; Nishimura K; Furukawa Y; Izumi C;
    Circ J; 2022 Oct; 86(11):1699-1707. PubMed ID: 35811134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.